DU
MTEM

Delphia (USA)’s Molecular Templates, Inc. MTEM Stock Holding History

Delphia (USA)’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,139
Closed -$67K – 420
2021
Q4 		$67K Buy
+1,139
New +$85.3K 0.07% 260

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Delphia (USA)'s MTEM Position: Q1 2022 in Review

Delphia (USA) sold out of Molecular Templates, Inc. (MTEM) in Q1 2022, closing a stake of 1,139 shares — an estimated $67K sold.

Delphia (USA) first reported a position in MTEM in Q4 2021 and held it in 1 quarter. The position peaked at $67K in Q4 2021. 77 funds tracked by Wall St. Rank hold MTEM as of Q1 2022.

  • Delphia (USA) reported no remaining Molecular Templates, Inc. position as of Q1 2022 after selling out during the quarter.
  • Delphia (USA) sold 1,139 Molecular Templates, Inc. shares in Q1 2022, an estimated $67K.
  • Delphia (USA) first reported a position in Molecular Templates, Inc. in Q4 2021 and held it in 1 quarter.
  • Delphia (USA)'s Molecular Templates, Inc. position peaked at $67K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.